Inhibition of PARP7 by RBN-2397 Activates the Type I Interferon Response in Tumors Leading to Robust Antitumor Activity
Time: 9:00 am
day: Day One
Details:
- Explore how PARP7 negatively regulates the type 1 interferon response in cancer cells
- Delving into discovery, development, and clinical progress of its inhibiton which triggers antitumor immunity
